Serum markers of inherited thrombophilia and antiphospholipid antibodies in pregnant women with previous history of severe pre-eclampsia;Marcadores séricos de trombofilias hereditárias e anticorpos antifosfolípides em gestantes com antecedentes de pré-eclâmpsia grave

Revista Brasileira de Ginecologia e Obstetricia

Volumn 34, Issue 1, 2012, Pages 40-46

  Figueiró Filho, Ernesto Antonio ^a   de Oliveveira, Vanessa Marcon ^a   Coelho, Lílian Rezende ^a   Breda, Ili ^a  

^a FEDERAL UNIVERSITY OF MATO GROSSO DO SUL   (Brazil)

Author keywords

Antiphospholipid syndrome; Biological makers; Pre eclampsia; Risk factors; Thrombophilia genetics

Indexed keywords

PHOSPHOLIPID ANTIBODY;

ADULT; ARTICLE; BLOOD; CASE CONTROL STUDY; FEMALE; HOSPITALIZATION; HUMAN; PREECLAMPSIA; PREGNANCY; PREGNANCY COMPLICATION; PROSPECTIVE STUDY; THROMBOPHILIA;

ADULT; ANTIBODIES, ANTIPHOSPHOLIPID; CASE-CONTROL STUDIES; FEMALE; HUMANS; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY COMPLICATIONS, HEMATOLOGIC; PROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; THROMBOPHILIA;

EID: 84857670091     PISSN: 01007203     EISSN: None     Source Type: Journal    
DOI: 10.1590/S0100-72032012000100008     Document Type: Article

References (40)

1. Ismail SK, Higgins JR. Hemostasis in pre-eclampsia. Semin Thromb Hemost. 2011;37(2):111-7.
2. Steegers EA, von Dadelszen P, Duvekot JJ, Pijnenborg R. Pre-eclampsia. Lancet. 2010;376(9741):631-44.
3. World Health Organization. WHO recommendations for prevention and treatment of pre-eclampsia and eclampsia. Geneve: WHO; 2011.
4. Kahn SR, Platt R, McNamara H, Rozen R, Chen MF, Genest J Jr, et al. Inherited thrombophilia and preeclampsia within a multicenter cohort: the Montreal Preeclampsia Study. Am J Obstet Gynecol. 2009;200(2):151.e1-9.
5. Cantwell R, Clutton-Brock T, Cooper G, Dawson A, Drife J, Garrod D, et al. Saving Mothersí Lives: reviewing maternal deaths to make motherhood safer: 2006-2008. The Eighth Report of the Confidential Enquiries into Maternal Deaths in the United Kingdom. BJOG. 2011;118(Suppl 1):1-203.
6. Duley L, Henderson-Smart DJ, Meher S, King JF. Antiplatelet agents for preventing pre-eclampsia and its complications. Cochrane Database Syst Rev. 2007;(2):CD004659.
7. Pabinger I. Thrombophilia and its impact on pregnancy. Thromb Res. 2009;123(Suppl 3):S16-21.
8. Akolekar R, Syngelaki A, Sarquis R, Zvanca M, Nicolaides KH. Prediction of early, intermediate and late pre-eclampsia from maternal factors, biophysical and biochemical markers at 11-13 weeks. Prenat Diagn. 2011;31(1):66-74.
9. Dodd JM, McLeod A, Windrim RC, Kingdom J. Antithrombotic therapy for improving maternal or infant health outcomes in women considered at risk of placental dysfunction. Cochrane Database Syst Rev. 2010;(6):CD006780.
10. Abou-Nassar K, Carrier M, Ramsay T, Rodger MA. The association between antiphospholipid antibodies and placenta mediated complications: a systematic review and meta-analysis. Thromb Res. 2011;128(1):77-85.
11. Walker MC, Ferguson SE, Allen VM. Heparin for pregnant women with acquired or inherited thrombophilias. Cochrane Database Syst Rev. 2003;(2):CD003580.
12. Sep S, Verbeek J, Koek G, Smits L, Spaanderman M, Peeters L. Clinical differences between early-onset HELLP syndrome and early-onset preeclampsia during pregnancy and at least 6 months postpartum. Am J Obstet Gynecol. 2010;202(3):271.e1-5.
13. Furuhashi M, Oda H, Imai N. HELLP syndrome after the improvement of coagulation and fibrinolysis parameters in severe pre-eclampsia. Int J Gynaecol Obstet. 1996;52(3):279-80.
14. Figueiró-Filho EA, Oliveira VM. Associação entre abortamentos recorrentes, perdas fetais, pré-eclâmpsia grave e trombofilias hereditárias e anticorpos antifosfolípides em mulheres do Brasil Central. Rev Bras Ginecol Obstet. 2007;29(11):561-7.
15. Pierangeli SS, Leader B, Barilaro G, Willis R, Branch DW. Acquired and inherited thrombophilia disorders in pregnancy. Obstet Gynecol Clin North Am. 2011;38(2):271-95, x.
16. Dusse LM, Carvalho MG, Bragança WF, Paiva SG, Godoi LC, Guimarães DA, et al. Inherited thrombophilias and pre-eclampsia in Brazilian women. Eur J Obstet Gynecol Reprod Biol. 2007;134(1):20-3.
17. Kupferminc MJ, Fait G, Many A, Gordon D, Eldor A, Lessing JB. Severe preeclampsia and high frequency of genetic thrombophilic mutations. Obstet Gynecol. 2000;96(1):45-9.
18. Spaanderman ME, Ekhart TH, van Eyck J, Cheriex EC, de Leeuw PW, Peeters LL. Latent hemodynamic abnormalities in symptom-free women with a history of preeclampsia. Am J Obstet Gynecol. 2000;182(1 Pt 1):101-7.
19. Benedetto C, Marozio L, Tavella AM, Salton L, Grivon S, Di Giampaolo F. Coagulation disorders in pregnancy: acquired and inherited thrombophilias. Ann N Y Acad Sci. 2010;1205:106-17.
20. Fogerty AE, Connors JM. Management of inherited thrombophilia in pregnancy. Curr Opin Endocrinol Diabetes Obes. 2009;16(6):464-9.
21. Ridker PM, Hennekens CH, Selhub J, Miletich JP, Malinow MR, Stampfer MJ. Interrelation of hyperhomocyst(e)inemia, factor V Leiden, and risk of future venous thromboembolism. Circulation. 1997;95(7):1777-82.
22. Nelen WL, Blom HJ, Steegers EA, den Heijer M, Eskes TK. Hyperhomocysteinemia and recurrent early pregnancy loss: a meta-analysis. Fertil Steril. 2000;74(6):1196-9.
23. Nelen WL, Blom HJ, Steegers EA, den Heijer M, Thomas CM, Eskes TK. Homocysteine and folate levels as risk factors for recurrent early pregnancy loss. Obstet Gynecol. 2000;95(4):519-24.
24. Silver RM, Zhao Y, Spong CY, Sibai B, Wendel G Jr, Wenstrom K, et al. Prothrombin gene G20210A mutation and obstetric complications. Obstet Gynecol. 2010;115(1):14-20.
25. Do Prado AD, Piovesan DM, Staub HL, Horta BL. Association of anticardiolipin antibodies with preeclampsia: a systematic review and meta-analysis. Obstet Gynecol. 2010;116(6):1433-43.
26. Von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP, et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Rev Esp Salud Publica. 2008;82(3):251-9.
27. Brasil. Ministério da Saúde. Departamento de Ações Programáticas Estratégicas. Área Técnica de Saúde da Mulher. Pré-natal e puerpério: atenção qualificada e humanizada - Manual Ténico. Brasília (DF): Ministério da Saúde; 2005.
28. Dreyfus M, Hedelin G, Kutnahorsky R, Lehmann M, Viville B, Langer B, et al. Antiphospholipid antibodies and preeclampsia: a case-control study. Obstet Gynecol. 2001;97(1):29-34.
29. Triplett DA, Stocker KF, Unger GA, Barna LK. The Textarin/Ecarin ratio: a confirmatory test for lupus anticoagulants. Thromb Haemost. 1993;70(6):925-31.
30. Faden D, Tincani A, Tanzi P, Spatola L, Lojacono A, Tarantini M, et al. Anti-beta 2 glycoprotein I antibodies in a general obstetric population: preliminary results on the prevalence and correlation with pregnancy outcome. Anti-beta2 glycoprotein I antibodies are associated with some obstetrical complications, mainly preeclampsia-eclampsia. Eur J Obstet Gynecol Reprod Biol. 1997;73(1):37-42.
31. Sibai B, Dekker G, Kupferminc M. Pre-eclampsia. Lancet. 2005;365(9461):785-99.
32. Plasencia W, Maiz N, Poon L, Yu C, Nicolaides KH. Uterine artery Doppler at 11 + 0 to 13 + 6 weeks and 21 + 0 to 24 + 6 weeks in the prediction of pre-eclampsia. Ultrasound Obstet Gynecol. 2008;32(2):138-46.
33. Miyakis S, Lockshin MD, Atsumi T, Branch DW, Brey RL, Cervera R, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost. 2006;4(2):295-306.
34. Abbassi-Ghanavati M, Greer LG, Cunningham FG. Pregnancy and laboratory studies: a reference table for clinicians. Obstet Gynecol. 2009;114(6):1326-31.
35. Bates SM, Greer IA, Pabinger I, Sofaer S, Hirsh J. American College of Chest Physicians. Venous thromboembolism, thrombophilia, antithrombotic therapy, and pregnancy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest. 2008;133(6 Suppl):844S-886S.
36. Ubbink JB, Hayward Vermaak WJ, Bissbort S. Rapid high-performance liquid chromatographic assay for total homocysteine levels in human serum. J Chromatogr. 1991;565(1-2):441-6.
37. Gris JC, Chauleur C, Molinari N, Marès P, Fabbro-Peray P, Quere I, et al. Addition of enoxaparin to aspirin for the secondary prevention of placental vascular complications in women with severe pre-eclampsia. The pilot randomised controlled NOH-PE trial. Thromb Haemost. 2011;106(6):1053-61.
38. Salim R, Czarnowicki T, Nachum Z, Shalev E. The impact of close surveillance on pregnancy outcome among women with a prior history of antepartum complications attributed to thrombosis: a cohort study. Reprod Biol Endocrinol. 2008;6:55.
39. Said JM, Higgins JR, Moses EK, Walker SP, Borg AJ, Monagle PT, et al. Inherited thrombophilia polymorphisms and pregnancy outcomes in nulliparous women. Obstet Gynecol. 2010;115(1):5-13.
40. Yalinkaya A, Erdemoglu M, Akdeniz N, Kale A, Kale E. The relationship between thrombophilic mutations and preeclampsia: a prospective case-control study. Ann Saudi Med. 2006;26(2):105-9.